Landsittel Michael

CIK 00016510362 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001651036

Recent Transactions

50 trades

Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2026-03-23+37,313→ 37,313 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−10,000→ 0 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−43,175→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,125→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−19,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−22,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−51,102→ 43,175 total
Award
Blueprint Medicines Corp
Common Stock
2025-07-17+21,353→ 94,277 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-05$88.80/sh−5,284→ 72,924 total
Award
Blueprint Medicines Corp
Common Stock
2025-03-01+11,000→ 78,208 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-03-01+22,000→ 22,000 total
Sale
Blueprint Medicines Corp
Common Stock
2024-08-15$95.23/sh−4,409→ 67,208 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-15$106.56/sh−1,364→ 71,617 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-15$107.17/sh−2,486→ 72,981 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-05-08$8.80/sh+1,818→ 75,467 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-05-08+26,363→ 0 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-05-08+1,818→ 0 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-05-08$1.87/sh+26,363→ 73,649 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-02$105.00/sh−10,000→ 47,286 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-05-02$36.05/sh+10,000→ 57,286 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-05-02−10,000→ 0 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-28$95.00/sh−5,000→ 47,286 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-03-28−5,000→ 10,000 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-03-28$36.05/sh+5,000→ 52,286 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-15$88.08/sh−1,638→ 49,753 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-03-15$36.05/sh+5,000→ 61,020 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-15$87.10/sh−2,675→ 58,345 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-15$88.94/sh−2,467→ 47,286 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-03-15−5,000→ 15,000 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-15$88.27/sh−1,413→ 56,932 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-15$88.88/sh−912→ 56,020 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-15$87.09/sh−4,629→ 51,391 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-07$90.69/sh−5,003→ 56,020 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-03-01+25,000→ 25,000 total
Award
Blueprint Medicines Corp
Common Stock
2024-03-01+12,500→ 61,023 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$45.72/sh−2,911→ 48,619 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$44.48/sh−96→ 48,523 total
Award
Blueprint Medicines Corp
Common Stock
2023-03-01+12,500→ 51,530 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-03-01+25,000→ 25,000 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-07$56.19/sh−1,047→ 39,030 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-03$60.27/sh−1,328→ 40,077 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-03-01+25,000→ 25,000 total
Award
Blueprint Medicines Corp
Common Stock
2022-03-01+12,500→ 41,405 total
Sale
Blueprint Medicines Corp
Common Stock
2021-03-04$86.61/sh−1,411→ 28,905 total
Sale
Blueprint Medicines Corp
Common Stock
2021-03-04$88.98/sh−96→ 30,316 total

Companies

Recent Filings

Address

C/O DAMORA THERAPEUTICS, INC., 221 CRESCENT ST, BUILDING 23, SUITE 105

WALTHAM, MA, 02453

View on SEC.gov